Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01227330 · ClinicalTrials.gov registry record · Phase 1
Pilot Program to Improve Statin Adherence and Lower Cholesterol in Older Adults
A Phase 1 study of Hypercholesterolemia and Medication Adherence, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- Phase 1
- Development phase
- 43
- Enrollment target
- 1
- Study location
NCT01227330: Completed Phase 1 study of Hypercholesterolemia and Medication Adherence, sponsored by University of Missouri-Columbia.
NCT01227330 is a Phase 1 study of Hypercholesterolemia and Medication Adherence that has completed, run by University of Missouri-Columbia. The registered enrollment target is 43 participants, below the 816-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01227330, a Phase 1 study of Hypercholesterolemia and Medication Adherence, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to pilot test a behavioral medication adherence (MA) intervention compared to control condition in older adults with low adherence to medication for hypercholesterolemia.
Conditions Studied
Interventions
- BEHAVIORAL Medication adherence intervention
- BEHAVIORAL Attention-control
Study Locations (1)
Missouri
- University of Missouri - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2010-10 |
| Est. Completion | 2014-02 |
| Phase | Phase 1 |
What the finished NCT01227330 record still lists
NCT01227330 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 816-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Hypercholesterolemia appearing as the primary indexed condition, and to 2 interventions - of which Medication adherence intervention is the first listed.
NCT01227330 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT01227330 about?
NCT01227330 is a clinical study titled "Pilot Program to Improve Statin Adherence and Lower Cholesterol in Older Adults". The purpose of this study is to pilot test a behavioral medication adherence (MA) intervention compared to control condition in older adults with low adherence to medication for hypercholesterolemia.
What is the current status of trial NCT01227330?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 43 participants. The study started on 2010-10. Estimated completion is 2014-02.
What conditions does trial NCT01227330 study?
This clinical trial studies the following conditions: Hypercholesterolemia, Medication Adherence.
What interventions are being tested in trial NCT01227330?
The interventions under investigation include: Medication adherence intervention (BEHAVIORAL), Attention-control (BEHAVIORAL).
Who is sponsoring clinical trial NCT01227330?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01227330 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypercholesterolemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01227330's enrollment target sits among peer trials
43 54th of 62 higher than 9 of 62 other Hypercholesterolemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypercholesterolemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With Hypercholesterolemia
COMPLETED · Phase 1
-
Study of the Response of Human Small Blood Vessels
COMPLETED · Phase 1
-
A Study of LY3015014 in Healthy Participants With High Cholesterol
COMPLETED · Phase 1
-
Safety, Tolerability, PK and PD of LGT209 in Healthy Volunteers and Patients With Hypercholesterolemia
COMPLETED · Phase 1
-
Potential Risk Factors for Stroke
COMPLETED · Phase 1
-
Ascending Multi-dose Study of REGN727(SAR236553) With and Without Concomitant Atorvastatin
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia